AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Takuma Wada
Public Documents
1
April 02, 2021
Successful rechallenge with cetuximab after progression with nivolumab for recurrent...
Yasuyuki Asada, Chitoshi Teramura, Takuma Wada, et al.
